Key Points
- Paola Arbour, Tenet Healthcare EVP, sold 6,500 shares on March 11 at an average price of $238.43 for about $1.55 million, reducing her stake by 18.16% to 29,291 shares (≈$6.98M).
- Tenet beat expectations with quarterly EPS of $4.70 (vs. $4.08 est.) and $5.53 billion in revenue (up 8.9% YoY), and set FY2026 guidance of EPS 16.190–18.470.
- Multiple brokerages have raised price targets and ratings, leaving a consensus rating of "Moderate Buy" with an average price target near $250.56.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) EVP Paola Arbour sold 6,500 shares of the company's stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares in the company, valued at approximately $6,983,853.13. This represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Tenet Healthcare Stock Performance
Shares of NYSE THC opened at $227.79 on Friday. The company has a 50 day simple moving average of $213.46 and a two-hundred day simple moving average of $203.99. The stock has a market cap of $19.81 billion, a price-to-earnings ratio of 14.71, a PEG ratio of 1.11 and a beta of 1.39. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $247.21.
Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts' consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business's quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the business. WCM Investment Management LLC raised its position in Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company's stock worth $102,657,000 after acquiring an additional 362,083 shares during the period. AlphaQuest LLC increased its stake in shares of Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company's stock worth $1,211,000 after purchasing an additional 4,202 shares in the last quarter. Winnow Wealth LLC acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth about $1,129,000. Cerity Partners LLC lifted its stake in Tenet Healthcare by 10.4% in the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company's stock valued at $21,230,000 after buying an additional 11,395 shares in the last quarter. Finally, Savant Capital LLC boosted its holdings in Tenet Healthcare by 27.5% in the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company's stock worth $3,430,000 after buying an additional 3,647 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages have recently issued reports on THC. Leerink Partners boosted their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the company an "outperform" rating in a report on Friday, February 20th. Royal Bank Of Canada lifted their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an "outperform" rating in a research report on Thursday, February 12th. Guggenheim upped their price objective on Tenet Healthcare from $271.00 to $283.00 and gave the stock a "buy" rating in a research report on Thursday. Weiss Ratings raised shares of Tenet Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a report on Monday, December 29th. Finally, Barclays raised their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an "overweight" rating in a research report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, Tenet Healthcare has a consensus rating of "Moderate Buy" and an average price target of $250.56.
Read Our Latest Stock Report on Tenet Healthcare
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
